vs

Side-by-side financial comparison of CollPlant Biotechnologies Ltd (CLGN) and OptimumBank Holdings, Inc. (OPHC). Click either name above to swap in a different company.

OptimumBank Holdings, Inc. is the larger business by last-quarter revenue ($13.6M vs $10.2M, roughly 1.3× CollPlant Biotechnologies Ltd). CollPlant Biotechnologies Ltd runs the higher net margin — 56.6% vs 35.7%, a 20.9% gap on every dollar of revenue. On growth, CollPlant Biotechnologies Ltd posted the faster year-over-year revenue change (15330.3% vs 32.0%).

CollPlant Biotechnologies Ltd is a regenerative medicine company focused on developing and commercializing advanced products using its proprietary plant-derived human collagen technology. Its core offerings cover wound care, soft tissue repair, and aesthetic medicine solutions, targeting key markets across North America, Europe, and Israel, serving healthcare providers in dermatology, orthopedics and cosmetic care segments.

OptimumBank Holdings, Inc. is a Florida-based bank holding company operating the local community bank OptimumBank. It offers retail and commercial banking products including deposit accounts, loans, mortgage services and wealth management, serving individual consumers and small-to-medium enterprises in southern Florida.

CLGN vs OPHC — Head-to-Head

Bigger by revenue
OPHC
OPHC
1.3× larger
OPHC
$13.6M
$10.2M
CLGN
Growing faster (revenue YoY)
CLGN
CLGN
+15298.3% gap
CLGN
15330.3%
32.0%
OPHC
Higher net margin
CLGN
CLGN
20.9% more per $
CLGN
56.6%
35.7%
OPHC

Income Statement — Q2 FY2023 vs Q4 FY2025

Metric
CLGN
CLGN
OPHC
OPHC
Revenue
$10.2M
$13.6M
Net Profit
$5.8M
$4.9M
Gross Margin
94.0%
Operating Margin
55.7%
47.5%
Net Margin
56.6%
35.7%
Revenue YoY
15330.3%
32.0%
Net Profit YoY
234.5%
22.9%
EPS (diluted)
$0.49
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLGN
CLGN
OPHC
OPHC
Q4 25
$13.6M
Q3 25
$13.0M
Q2 25
$12.1M
Q1 25
$10.7M
Q4 24
$10.3M
Q3 24
$10.1M
Q2 24
$9.9M
Q1 24
$9.0M
Net Profit
CLGN
CLGN
OPHC
OPHC
Q4 25
$4.9M
Q3 25
$4.3M
Q2 25
$3.6M
Q1 25
$3.9M
Q4 24
$3.9M
Q3 24
$3.3M
Q2 24
$3.5M
Q1 24
$2.4M
Operating Margin
CLGN
CLGN
OPHC
OPHC
Q4 25
47.5%
Q3 25
43.5%
Q2 25
40.2%
Q1 25
48.8%
Q4 24
51.5%
Q3 24
44.0%
Q2 24
46.9%
Q1 24
35.9%
Net Margin
CLGN
CLGN
OPHC
OPHC
Q4 25
35.7%
Q3 25
33.2%
Q2 25
29.8%
Q1 25
36.3%
Q4 24
38.3%
Q3 24
32.8%
Q2 24
35.2%
Q1 24
26.4%
EPS (diluted)
CLGN
CLGN
OPHC
OPHC
Q4 25
$-0.08
Q3 25
$0.18
Q2 25
$0.29
Q1 25
$0.32
Q4 24
$-0.17
Q3 24
$0.15
Q2 24
$0.34
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLGN
CLGN
OPHC
OPHC
Cash + ST InvestmentsLiquidity on hand
$22.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$36.0M
$121.9M
Total Assets
$41.6M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Stockholders' Equity
CLGN
CLGN
OPHC
OPHC
Q4 25
$121.9M
Q3 25
$116.9M
Q2 25
$111.3M
Q1 25
$108.0M
Q4 24
$103.2M
Q3 24
$92.7M
Q2 24
$87.0M
Q1 24
$83.0M
Total Assets
CLGN
CLGN
OPHC
OPHC
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$999.1M
Q1 25
$977.5M
Q4 24
$932.9M
Q3 24
$945.2M
Q2 24
$899.8M
Q1 24
$940.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLGN
CLGN
OPHC
OPHC
Operating Cash FlowLast quarter
$17.8M
Free Cash FlowOCF − Capex
$16.9M
FCF MarginFCF / Revenue
124.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
3.68×
TTM Free Cash FlowTrailing 4 quarters
$27.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLGN
CLGN
OPHC
OPHC
Q4 25
$17.8M
Q3 25
$1.9M
Q2 25
$6.2M
Q1 25
$3.1M
Q4 24
$15.6M
Q3 24
$4.0M
Q2 24
$3.1M
Q1 24
$2.5M
Free Cash Flow
CLGN
CLGN
OPHC
OPHC
Q4 25
$16.9M
Q3 25
$1.9M
Q2 25
$5.9M
Q1 25
$2.9M
Q4 24
$14.6M
Q3 24
$3.9M
Q2 24
$2.7M
Q1 24
$2.3M
FCF Margin
CLGN
CLGN
OPHC
OPHC
Q4 25
124.6%
Q3 25
14.7%
Q2 25
48.5%
Q1 25
26.8%
Q4 24
141.9%
Q3 24
38.3%
Q2 24
27.5%
Q1 24
25.4%
Capex Intensity
CLGN
CLGN
OPHC
OPHC
Q4 25
6.6%
Q3 25
0.0%
Q2 25
2.5%
Q1 25
2.7%
Q4 24
9.6%
Q3 24
1.5%
Q2 24
3.6%
Q1 24
2.9%
Cash Conversion
CLGN
CLGN
OPHC
OPHC
Q4 25
3.68×
Q3 25
0.44×
Q2 25
1.71×
Q1 25
0.81×
Q4 24
3.95×
Q3 24
1.21×
Q2 24
0.89×
Q1 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons